Ibrutinib and venetoclax for first-line treatment of CLL

Research output: Contribution to journalArticlepeer-review

368 Scopus citations

Fingerprint

Dive into the research topics of 'Ibrutinib and venetoclax for first-line treatment of CLL'. Together they form a unique fingerprint.

Medicine & Life Sciences